KEYS vs PRCT · P/E 57, rev $4.98B vs rev $224.5M
Keysight Technologies Inc (KEYS) versus Procept Biorobotics Corp (PRCT) — a side-by-side from cached financials, not a winner call.
Keysight Technologies Inc (KEYS) is a scientific & technical instruments company listed on US.
Procept Biorobotics Corp (PRCT) is a medical devices company listed on US.
Latest reported KEYS revenue for 2024-10-31 was $4.98B. Net income was $614.0M. Revenue was down 8.9% from 2023-10-31 to 2024-10-31. KEYS currently screens at market cap $59.84B and trailing P/E 56.5.
Latest reported PRCT revenue for 2024-12-31 was $224.5M. Net income was -$91.4M. Revenue was up 64.8% from 2023-12-31 to 2024-12-31. PRCT currently screens at market cap $1.52B.
KEYS currently screens at market cap $59.84B and trailing P/E 56.5. PRCT currently screens at market cap $1.52B.
Not investment advice. Open the KEYS and PRCT stock pages for the full models.
Not investment advice.